Revenue, last quarter
$3.2M
+8.4% vs same quarter last year
Net income
−$1.1M
−70.3% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$32K
+95.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $11.4M | −$3M |
| FY24 | $8.7M | −$3.3M |
| FY23 | $4.1M | −$3.2M |
| FY22 | $2M | −$4.7M |
| FY21 | $1.6M | −$4.3M |
| FY20 | $674K | −$2.3M |
| FY19 | $717K | −$1.9M |
| FY18 | $2.2M | −$1.9M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 39.5% | −29.3% | −26.3% |
| FY24 | 31.6% | −40.9% | −37.8% |
| FY23 | 9.1% | −85% | −77.2% |
| FY22 | 12.5% | −163.5% | −231.7% |
| FY21 | 0.5% | −165.7% | −277.9% |
| FY20 | −43.2% | −335.3% | −335.9% |
| FY19 | −19.1% | −268.3% | −268.2% |
| FY18 | 23.2% | −85.3% | −85.3% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$1.4M |
| FY24 | −$4.3M |
| FY23 | −$3.9M |
| FY22 | −$3.1M |
| FY21 | −$3M |
| FY20 | −$2.1M |
| FY19 | −$1.8M |
| FY18 | - |
| FY17 | - |
- Nexgel
- Healthcare median
Show the numbers
| Year | Nexgel | Healthcare median |
|---|---|---|
| FY25 | −26.3% | −30.6% |
| FY24 | −37.8% | −47% |
| FY23 | −77.2% | −58% |
| FY22 | −231.7% | −80.4% |
| FY21 | −277.9% | −71.8% |
| FY20 | −335.9% | −62.2% |
| FY19 | −268.2% | −46.2% |
| FY18 | −85.3% | −49.6% |
| FY17 | - | −45.9% |